Phenotypic circulating tumor cell (CTC) classifier of genomic instability (GI) associates with improved overall survival (OS) for metastatic castration-resistant prostate cancer (mCRPC) patients (pts) receiving platinum agents in addition to taxanes Meeting Abstract

  

Authors:	Scher, H.; Graf, R. P.; Jendrisak, A.; McLaughlin, B.; Barnett, E.; Schreiber, N. A.; Lee, J.; Kelvin, J.; Wang, Y.; Landers, M.; Dittamore, R.
Abstract Title:	Phenotypic circulating tumor cell (CTC) classifier of genomic instability (GI) associates with improved overall survival (OS) for metastatic castration-resistant prostate cancer (mCRPC) patients (pts) receiving platinum agents in addition to taxanes
Meeting Title:	42nd ESMO Congress (ESMO 2017)
Journal Title:	Annals of Oncology
Volume:	28
Issue:	Suppl. 5
Meeting Dates:	2017 Sep 8-12
Meeting Location:	Madrid, Spain
ISSN:	0923-7534
Publisher:	Oxford University Press
Date Published:	2017-09-01
Start Page:	mdx370.039
Language:	English
ACCESSION:	WOS:000411324002013
PROVIDER:	wos
DOI:	10.1093/annonc/mdx370.039
Notes:	Meeting Abstract: 822P -- Appears on page 285 of the abstract book -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/117040